HCPLive Network

Multiple Sclerosis

Multiple sclerosis flare-ups in animal models were blocked after a protein treatment, according to a study published in Molecular Psychiatry.
Genzyme announced the FDA has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.
The launch of MS Radio aims to spread information, host discussions, and present features for multiple sclerosis patients, caregivers, and clinicians.
Multiple sclerosis is almost conclusively an immune system disease, not a nervous system disease, according to a study published in Nature.
In an 18-year study, researchers tracked cognitive decline in patients with multiple sclerosis.
Vaccines do not contribute to multiple sclerosis or other central nervous system demyelinating syndrome onset, according to a study published in JAMA Neurology.
Multiple Sclerosis Latest News
Multiple Sclerosis Clinical Trials
Multiple Sclerosis Resources